Restless legs syndrome is associated with cardio/cerebrovascular events and mortality in end-stage renal disease

European Journal of Neurology

Volumn 22, Issue 1, 2015, Pages 142-149

  Lin, C H ^a   Sy, H N ^b   Chang, H W ^a,c   Liou, H H ^d   Lin, C Y ^e   Wu, V C ^a   Wu, S L ^b   Chang, C C ^b   Chiu, P F ^b   Li, W Y ^a   Lin, S Y ^a   Wu, K D ^a   Chen, Y M ^a   Wu, R M ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c Far Eastern Polyclinic   (Taiwan)

^d Hsin Jen Hospital   (Taiwan)

^e EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

Cardiovascular disease; Cerebrovascular disease; End stage renal disease; Mortality; Restless legs syndrome; Stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DEATH; DISEASE SEVERITY; END STAGE RENAL DISEASE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTLESS LEGS SYNDROME; SENSITIVITY ANALYSIS; AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; COMPLICATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX;

EID: 84922962974     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12545     Document Type: Article

References (22)

1. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119.
2. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010; 6: 337-346.
3. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28: 372-378.
4. Lin CH, Wu VC, Li WY, et al. Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan. Eur J Neurol 2013; 20: 1025-1031.
5. Szentkirályi A, Winter AC, Schürks M, et al. Restless legs syndrome and all-cause mortality in four prospective cohort studies. BMJ Open 2012; 2: pii: e001652.
6. La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 2011; 26: 1976-1983.
7. Li Y, Wang W, Winkelman JW, et al. Prospective study of restless legs syndrome and mortality among men. Neurology 2013; 81: 52-59.
8. Winkelman JW, Shahar E, Sharief I, et al. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008; 70: 35-42.
9. Li Y, Walters AS, Chiuve SE, et al. Prospective study of restless legs syndrome and coronary heart disease among women. Circulation 2012; 126: 1689-1694.
10. Winter AC, Schürks M, Glynn RJ, et al. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open 2012; 2: e000866.
11. Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev 2012; 16: 309-339.
12. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
13. System, U.S.R.D. USRDS 2007 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2007.
14. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-132.
15. Tsai PS, Wang SY, Wang MY, et al. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res 2005; 14: 1943-1952.
16. Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011; 40: 139-146.
17. Cirignotta F, Mondini S, Santoro A, Ferrari G, Gerardi R, Buzzi G. Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis. Am J Kidney Dis 2002; 40: 302-306.
18. Gholamrezaei A, Amra B, Mortazavi M. Cardiovascular risk and mortality in end-stage renal disease patients with restless legs syndrome; need for further investigation and looking for underlying mechanisms. Sleep Med 2013; 14: 385-386.
19. Elwood P, Hack M, Pickering J, et al. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006; 60: 69-73.
20. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009; 32: 589-597.
21. Giannini G, Zanigni S, Melotti R, et al. Association between restless legs syndrome and hypertension: a preliminary population-based study in South Tyrol, Italy. Eur J Neurol 2014; 21: 72-78.
22. Cappuccio FP, D'Elia L, Strazzullo P, et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010; 33: 585-592.